Literature DB >> 27017339

The accuracy of the anti-phospholipase A2 receptor antibody in the diagnosis of idiopathic membranous nephropathy: a comparison of different cutoff values as measured by the ELISA method.

Yanna Dou1,2, Li Zhang1,2, Dong Liu3,4, Chunyan Wang1,2,5, Songxia Quan1,2,5, Shuang Ma1,2, Jing Xiao1,2, Genyang Cheng1,2, Zhangsuo Liu1,2, Zhanzheng Zhao6,7.   

Abstract

AIM: Recent studies have revealed that anti-phospholipase A2 receptor antibodies (aPLA2R-ABs) may play a role in the diagnosis of idiopathic membranous nephropathy (IMN). We will investigate the application of an aPLA2R-AB with different cutoff values for diagnosing IMN.
METHODS: From August 2014 to December 2014, patients with proteinuria greater than 1 g/day were screened at the First Affiliated Hospital of Zhengzhou University. Patients were divided into the IMN and non-IMN groups based on the results of renal biopsy. The sensitivity, specificity, and receiver operating characteristic (ROC) curve of aPLA2R-AB for diagnosing IMN were analyzed.
RESULTS: A total of 229 patients (113 males, average age of 45.3 ± 15.8 years) were enrolled in this study, and 118 patients were diagnosed with IMN. The sensitivity/specificity of aPLA2R-AB in the diagnosis of IMN was 65.3/97.3 %, 60.2/97.3 %, and 45.8/97.3 % for the different cutoff values (14, 20, and 40 RU/ml). The area of the ROC curve was 0.87.
CONCLUSION: Anti-PLA2R-AB with a cutoff value of 14 RU/ml based on the ELISA method plays an important role in the diagnosis of IMN.

Entities:  

Keywords:  Anti-PLA2R antibody; ELISA method; Idiopathic membranous nephropathy; Sensitivity; Specificity

Mesh:

Substances:

Year:  2016        PMID: 27017339     DOI: 10.1007/s11255-016-1263-6

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  16 in total

1.  Recombinant production and properties of binding of the full set of mouse secreted phospholipases A2 to the mouse M-type receptor.

Authors:  Morgane Rouault; Catherine Le Calvez; Eric Boilard; Fanny Surrel; Alan Singer; Farideh Ghomashchi; Sofiane Bezzine; Sabine Scarzello; James Bollinger; Michael H Gelb; Gérard Lambeau
Journal:  Biochemistry       Date:  2007-02-13       Impact factor: 3.162

2.  Circulating antipodocyte antibodies in membranous nephropathy: pathophysiologic and clinical relevance.

Authors:  Pierre Ronco; Hanna Debiec; Hirokazu Imai
Journal:  Am J Kidney Dis       Date:  2013-05-02       Impact factor: 8.860

3.  Anti-phospholipase A2 receptor antibody in membranous nephropathy.

Authors:  Weisong Qin; Laurence H Beck; Caihong Zeng; Zhaohong Chen; Shijun Li; Ke Zuo; David J Salant; Zhihong Liu
Journal:  J Am Soc Nephrol       Date:  2011-05-12       Impact factor: 10.121

4.  [Epidemiology of glomerular disease in adults: a database review].

Authors:  Venice Chávez Valencia; Citlalli Orizaga de La Cruz; Jesús Guillermo Becerra Fuentes; Francisco Fuentes Ramírez; Renato Parra Michel; Yuritomo Aragaki; Isela Márquez Magaña; Héctor Leonardo Pazarin Villaseñor; Martha Arisbeth Villanueva Pérez; Mario Alberto García Cárdenas
Journal:  Gac Med Mex       Date:  2014 Sep-Oct       Impact factor: 0.302

5.  Anti-phospholipase A₂ receptor antibodies correlate with clinical status in idiopathic membranous nephropathy.

Authors:  Julia M Hofstra; Laurence H Beck; David M Beck; Jack F Wetzels; David J Salant
Journal:  Clin J Am Soc Nephrol       Date:  2011-04-07       Impact factor: 8.237

6.  Cloning and expression of a membrane receptor for secretory phospholipases A2.

Authors:  G Lambeau; P Ancian; J Barhanin; M Lazdunski
Journal:  J Biol Chem       Date:  1994-01-21       Impact factor: 5.157

7.  M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy.

Authors:  Laurence H Beck; Ramon G B Bonegio; Gérard Lambeau; David M Beck; David W Powell; Timothy D Cummins; Jon B Klein; David J Salant
Journal:  N Engl J Med       Date:  2009-07-02       Impact factor: 91.245

8.  Glomerular diseases in a Hispanic population: review of a regional renal biopsy database.

Authors:  Luis Fernando Arias; Jorge Henao; Rubén Darío Giraldo; Nelson Carvajal; Joaquin Rodelo; Mario Arbeláez
Journal:  Sao Paulo Med J       Date:  2009       Impact factor: 1.044

9.  Autoantibodies against phospholipase A2 receptor in Korean patients with membranous nephropathy.

Authors:  Yun Jung Oh; Seung Hee Yang; Dong Ki Kim; Shin-Wook Kang; Yon Su Kim
Journal:  PLoS One       Date:  2013-04-26       Impact factor: 3.240

10.  Antiphospholipase A₂ receptor autoantibodies: a comparison of three different immunoassays for the diagnosis of idiopathic membranous nephropathy.

Authors:  Astrid Behnert; Mario Schiffer; Janina Müller-Deile; Laurence H Beck; Michael Mahler; Marvin J Fritzler
Journal:  J Immunol Res       Date:  2014-04-09       Impact factor: 4.818

View more
  11 in total

1.  Comparison of measurements of anti-PLA2R antibodies in Japanese patients with membranous nephropathy using in-house and commercial ELISA.

Authors:  Hajime Kaga; Atsushi Komatsuda; Soh Yamamoto; Tadashi Kikuchi; Mika Kamata; Akiko Sato; Masafumi Odaka; Shin-Ichi Yokota; Naoto Takahashi; Hideki Wakui
Journal:  Clin Exp Nephrol       Date:  2019-02-13       Impact factor: 2.801

Review 2.  The Role of Anti-PLA2R and Anti-THSD7A Antibodies in the Pathogenesis and Diagnostics of Primary Membranous Nephropathy: A Review of Current Knowledge for Clinical Practice.

Authors:  Iwona Smarz-Widelska; Dariusz Chojęta; Małgorzata M Kozioł
Journal:  Int J Environ Res Public Health       Date:  2022-04-27       Impact factor: 4.614

3.  Definition of a new cut-off for the anti-phospholipase A2 receptor (PLA2R) autoantibody immunoassay in patients affected by idiopathic membranous nephropathy.

Authors:  Marilina Tampoia; Francesca Migliucci; Chiara Villani; Letizia Abbracciavento; Michele Rossini; Ruggiero Fumarulo; Loreto Gesualdo; Vincenzo Montinaro
Journal:  J Nephrol       Date:  2018-09-05       Impact factor: 3.902

4.  Ultrasensitive Quantitation of Anti-Phospholipase A2 Receptor Antibody as A Diagnostic and Prognostic Indicator of Idiopathic Membranous Nephropathy.

Authors:  Qiuhua Zhang; Biao Huang; Xiaobin Liu; Bin Liu; Yi Zhang; Zhijian Zhang; Jia Hua; Yun Fan; Ling Hu; Meijuan Meng; Mian Wu; Liang Wang; Zhigang Hu; Zhuxing Sun
Journal:  Sci Rep       Date:  2017-09-21       Impact factor: 4.379

5.  The Effect of Mycophenolate Mofetil versus Cyclosporine as Combination Therapy with Low Dose Corticosteroids in High-risk Patients with Idiopathic Membranous Nephropathy: a Multicenter Randomized Trial.

Authors:  Ji Young Choi; Dong Ki Kim; Yang Wook Kim; Tae Hyun Yoo; Jung Pyo Lee; Hyun Chul Chung; Kyu Hyang Cho; Won Suk An; Duk Hyun Lee; Hee Yeon Jung; Jang Hee Cho; Chan Duck Kim; Yong Lim Kim; Sun Hee Park
Journal:  J Korean Med Sci       Date:  2018-02-26       Impact factor: 2.153

6.  A New Chemiluminescence Immunoassay for Phospholipase A2 Receptor 1 Autoantibodies Allows Early Identification of Autoantibody Recurrence in Patients With Membranous Nephropathy.

Authors:  Elion Hoxha; Rolf A K Stahl; Linda Reinhard; Alexander Kühnl; Wolfgang Schlumberger; Cornelia Dähnrich
Journal:  Kidney Int Rep       Date:  2021-01-13

7.  Rapid, quantitative, and high-sensitivity detection of anti-phospholipase A2 receptor antibodies using a novel CdSe/ZnS-based fluorescence immunosorbent assay.

Authors:  Chenxi Li; Manyun Qian; Qiaozhen Hong; Xiaohong Xin; Zichun Sun; Yafeng Li; Bo Tang; Bing Gu
Journal:  Sci Rep       Date:  2021-04-22       Impact factor: 4.379

8.  Diagnostic Test Accuracy of Serum Anti-PLA2R Autoantibodies and Glomerular PLA2R Antigen for Diagnosing Idiopathic Membranous Nephropathy: An Updated Meta-Analysis.

Authors:  Weiying Li; Yuliang Zhao; Ping Fu
Journal:  Front Med (Lausanne)       Date:  2018-04-26

9.  Development of a Standardized Chemiluminescence Immunoassay for the Detection of Autoantibodies Against Human M-Type Phospholipase A2 Receptor in Primary Membranous Nephropathy.

Authors:  Cornelia Dähnrich; Sandra Saschenbrecker; Iva Gunnarsson; Wolfgang Schlumberger; Pierre Ronco; Hanna Debiec
Journal:  Kidney Int Rep       Date:  2019-11-22

10.  Serum Levels of BAFF and APRIL Predict Clinical Response in Anti-PLA2R-Positive Primary Membranous Nephropathy.

Authors:  Giuseppe Stefano Netti; Barbara Infante; Federica Spadaccino; Giulia Godeas; Maria Grazia Corallo; Concetta Prisciandaro; Laura Croce; Mario Rotondi; Loreto Gesualdo; Giovanni Stallone; Giuseppe Grandaliano; Elena Ranieri
Journal:  J Immunol Res       Date:  2019-11-05       Impact factor: 4.818

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.